Silveray is a technology company specializing in the development of innovative direct conversion detectors for X-ray imaging, catering to healthcare, industrial, and security applications. Founded in 2018 by Professor Ravi Silva from the University of Surrey, the company is headquartered in Stockport, United Kingdom. Capitalizing on its cutting-edge nanoparticle-based technology, Silveray has raised approximately $2.87 million from investors such as Innovate UK and Northern Gritstone.
Attribute | Information |
---|---|
Founding Date | 2018 |
Headquarters | Stockport, United Kingdom |
Founders | Professor Ravi Silva |
Revenue | Not disclosed |
Profits | Not disclosed |
Key Investors | Northern Gritstone, ACF Investors, Cambridge Angels |
Industry | Medical Devices & Equipment |
Number of Employees | 14 |
Silveray was spun out from the Advanced Technology Institute at the University of Surrey in 2018. Professor Ravi Silva initially established the company to explore and validate innovative X-ray detection technology. The foundational research was supported through pre-seed funding in 2019, which focused on developing the core direct conversion technology using nanoparticle-based materials. This innovation was aimed at transforming the traditional methods used in x-ray image capture into a more efficient, high-resolution, and cost-effective solution.
Silveray has pioneered in developing nanoparticle-based direct conversion materials for X-ray detectors that offer higher imaging performance and efficiency. Their technology transforms conventional X-ray processes by integrating semiconductor ink directly onto pixel backplanes, making their detectors both flexible and cost-effective. Some of the company’s key achievements include:
Currently, Silveray is cementing its position in the X-ray imaging market by focusing on product development and strategic partnerships. The company plans to launch its first commercial product in 2025, particularly targeting the industrial sector for radiographic film replacement. Silveray is well-positioned to potentially disrupt the traditional X-ray market with its flexible, high-performance detectors that promise both cost-effectiveness and improved functionality. Their strategic relocation to Greater Manchester has facilitated access to local talent and advanced research resources.
Silveray stands as a promising start-up in the medical imaging and industrial radiography markets. By developing innovative X-ray imaging solutions, the company is poised to revolutionize how X-ray systems operate across industries. With continued support from strategic investors and an upcoming product launch, Silveray is on track to reshape the X-ray imaging landscape globally, offering superior digital solutions tailor-made for diverse applications.